menu search

Marinus: transforming the seizure market with ganaxolone (rating upgrade)

Marinus Pharmaceuticals has pivoted from postpartum depression to focus on seizure disorders, leading to FDA approval for Ztalmy (ganaxolone) for trea...

June 22, 2023, 5:55 pm

Sernova to present updated interim phase 1/2 clinical data on cell pouch system™ during oral presentation at american diabetes association 83rd scientific sessions

Company to host in-person only analyst and investor event at an offsite location following the presentation on Saturday, June 24 at the ADA Scientific...

June 22, 2023, 5:16 pm

Ewu: the entire united kingdom is in trouble

The economic landscape in the United Kingdom, as covered by iShares MSCI United Kingdom ETF, is undergoing a tumultuous phase, with inflation rates so...

June 22, 2023, 5:00 pm

Why uniqure stock cratered this week

Wednesday, uniQure announced interim phase 1/2 results for its experimental Huntington's disease gene t...

June 22, 2023, 3:03 pm

Oncolytics biotech's stock soars 25% after pelareorep is selected for inclusion in late-stage pancreatic cancer trial

The stock of Oncolytics Biotech Inc. ONCY, +23.25% soared 25% Thursday, after the San Diego-based company said its pelareorep therapy has been selecte...

June 22, 2023, 1:12 pm

Marvel discovery announces follow-up drill program at klr-walker uranium project

Marvel Discovery has announced a follow-up drill program at the KLR-Walker uranium project in the Athabasca Basin targeting the DD Zone and Highway Z...

June 22, 2023, 11:38 am

Praxis precision medicines announces closing of financing and reiterates corporate priorities

Strong demand for financing including full exercise of overallotment option with net proceeds of $63.3 million Cash runway extended into Q1 2025 ...

June 22, 2023, 11:00 am

Mindset pharma's phase 2 psilocin prodrug study gets green light from uk regulators

Mindset Pharma Inc (CSE:MSET, OTCQB:MSSTF) has received approval from the UK Medicines and Healthcare products Regulatory Authority and the Research E...

June 22, 2023, 10:45 am

Enphase energy, inc. (enph) is attracting investor attention: here is what you should know

Zacks.com users have recently been watching Enphase Energy (ENPH) quite a bit. Thus, it is worth knowin...

June 22, 2023, 10:21 am

Reviva pharmaceuticals announces 80% global enrollment update for pivotal phase 3 recover study evaluating brilaroxazine for schizophrenia

– Enrollment ongoing at multiple sites in the US, Europe, and Asia – – Multifaceted activity of serotonin-dopamine stabilizer brilaroxazine supp...

June 22, 2023, 10:00 am

Progressive planet names steve gurney as president to lead commercialization phase of cleantech innovations

Progressive Planet, a leading developer of CleanTech solutions for the planet, has appointed Steve Gurney as its new president as the company enters t...

June 22, 2023, 9:21 am

Madrigal pharmaceuticals presents phase 3 maestro-nash data during the opening general session of the easl congress™

First scientific presentation of detailed MAESTRO-NASH results confirms achievement of primary endpoints across multiple patient subgroups Noninvasive...

June 22, 2023, 7:30 am

Poolbeg pharma consortium moves into important new phase as it develops a breakthrough oral vaccine

Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) said important preclinical work is starting on a programme to produce a breakthrough oral vaccine - a vent...

June 22, 2023, 2:40 am

Roivant to host investor call at 8:00 am et on thursday, june 22 to review results from the chronic period of tuscany-2, a large global phase 2b study of rvt-3101 (anti-tl1a antibody) in ulcerative co

BASEL, Switzerland and LONDON and NEW YORK and BOSTON, June 21, 2023 (GLOBE NEWSWIRE) — Roivant Sciences (Nasdaq: ROIV) today announced that it will...

June 21, 2023, 9:00 pm

Eloxx pharmaceuticals to host investor and analyst call on alport syndrome

Globally renowned Alport syndrome experts will provide key insights Eloxx recently announced achievement of remission in one patient in its ...

June 21, 2023, 5:30 pm

Usd/jpy: 200-dma near 138/137.20 expected to provide support – socgen

After a brief pause, USD/JPY has resumed its phase of rebound. The pair is now challenging a multi-mont...

June 21, 2023, 3:14 pm

Enphase (enph) expands solar energy systems in brasilia

Enphase (ENPH) simplifies residential energy monitoring and insights into operations and maintenance fo...

June 21, 2023, 11:49 am

Why uniqure stock is crashing today

uniQure reported interim data from a phase 1/2 study of AMT-130 in treating Huntington's disease. The r...

June 21, 2023, 11:46 am

Xeris biopharma says first participant dosed in phase 2 clinical study of investigational subcutaneous levothyroxine in patients with hypothyroidism

Xeris Biopharma Holdings (NASDAQ:XERS) told investors that the first participant has been dosed in a multi-center, open-label, ...

June 21, 2023, 9:38 am

Biovie to present phase 3 study data at american diabetes association conference

BioVie Inc (NASDAQ:BIVI) said it will present an abstract showcasing baseline data from its phase 3 st...

June 21, 2023, 9:17 am


Search within

Pages Search Results: